Chris Freeman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Chris Freeman

Form 4 holding Chief Commercial Officer

Guardant Health, Inc.

Security class
Performance-Based Restricted Stock Units
Shares / value
0
Estimated value
$534,444
Report date
15 Mar 2026
Price
$46.98
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer

Guardant Health, Inc.

Security class
Restricted Stock Units
Shares / value
10,339
Estimated value
$424,870
Report date
01 Apr 2026
Price
$42.47
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer

Guardant Health, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
701
Estimated value
Report date
22 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Chris Freeman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .